Valgen Medtech

company

About

Valgen focus on treatment technologies and systemic solutions for heart disease, especially for mitral and tricuspid valve lesions.

Details

Last Funding Type
Series B
Last Funding Money Raised
$188M
Industries
Health Care,Health Diagnostics,Hospital
Founded date
Jan 1, 2015
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$188M
Valgen Medtech has raised a total of $188M in funding over 2 rounds. Their latest funding was raised on May 6, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 6, 2021 Series B $188M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Valgen Medtech is funded by 1 investors. China Life Healthcare Fund are the most recent investors.
Investor Name Lead Investor Funding Round
China Life Healthcare Fund Series B